Client News

CatalYm to Present Initial Data of First-in-Human Trial of GDF-15 neutralizing antibody CTL-002 at the 2021 ASCO Annual Meeting

XPhyto Rapid Point-of-Care COVID-19 PCR Test Offered for Sale in Germany

InflaRx Announces Positive Topline Results for Vilobelimab from the U.S. Phase II ANCA-Associated Vasculitis IXPLORE Study

CatalYm GmbH: CatalYm Appoints Industry Leader Dr. Phil L’Huillier as Chief Executive Officer

HeartBeat.bio AG to Reinvent Cardiac Drug Discovery

VAXIMM Announces Participation at Scientific and Industry Events in May

Newron announces Paragraph IV ANDA filing for Xadago(R) (safinamide) in the USA

Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2021

Vetter and Rentschler Biopharma Further Strengthen their Strategic Alliance

XPhyto Pursues Market Access in Israel for its COVID-19 PCR Rapid Test